Pictet Asset Management (UK)’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $14M | Sell |
99,155
-252,400
| -72% | -$35.7M | 0.02% | 599 |
|
|
2021
Q1 | $35.1M | Sell |
351,555
-1,423
| -0.4% | -$142K | 0.04% | 402 |
|
|
2020
Q4 | $43.6M | Sell |
352,978
-115,400
| -25% | -$14.3M | 0.06% | 328 |
|
|
2020
Q3 | $45.6M | Buy |
468,378
+135,403
| +41% | +$13.2M | 0.07% | 287 |
|
|
2020
Q2 | $52M | Buy |
332,975
+68,601
| +26% | +$10.7M | 0.09% | 249 |
|
|
2020
Q1 | $38.2M | Buy |
264,374
+113,312
| +75% | +$16.4M | 0.08% | 254 |
|
|
2019
Q4 | $30.9M | Buy |
+151,062
| New | +$30.9M | 0.05% | 349 |
|